Triglycerides Blood Test: Normal Ranges & Causes | Peptide Chats
Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Triglycerides blood test

Triglycerides. Also called: TG, Serum triglycerides, Triacylglycerols

Biomarker guideLast updated: November 2, 2026

Triglycerides are the main fat in the blood, carried in VLDL and other triglyceride-rich particles. Below 150 mg/dL is normal; 500 or higher is very high. They rise after meals, so a non-fasting result can read higher than a fasting one.

LOINC 2571-8Heart

One of the four values on a standard Lipid Panel. The panel page also covers the advanced tests, ApoB and Lp(a).

At a glance

What it measuresThe triglyceride (fat) carried in the blood, mostly in VLDL and other triglyceride-rich particles.
SampleSerum or plasma. Non-fasting is fine in a lipid panel; a standalone triglyceride test asks for an overnight fast.
Adult categoriesNormal below 150 mg/dL; borderline high 150-199; high 200-499; very high 500 or higher.
Peptides that move itLowered by Tirzepatide, Semaglutide, Liraglutide and Tesamorelin; raised by GnRH drugs.
Lab codeLOINC 2571-8 (Labcorp 001172, Quest 896)

What are Triglycerides?

Triglycerides are the main form of fat in the blood. They travel in triglyceride-rich lipoproteins such as VLDL. Partly broken-down VLDL particles, called remnant lipoproteins, are treated by ATP III as atherogenic. High triglycerides predict heart disease and, when very high, acute pancreatitis.

Sources: [1] [2] [3] [4]

How it is made and regulated

Where it is made

ATP III lists the usual drivers of high triglycerides: obesity and overweight, physical inactivity, cigarette smoking, excess alcohol, very high-carbohydrate diets (more than 60% of energy), type 2 diabetes, chronic kidney failure, nephrotic syndrome, some drugs (corticosteroids, estrogens, retinoids, high-dose beta-blockers) and inherited disorders.

Sources: [1] [2]

What controls it

Triglycerides rise after each meal and then fall as the particles are cleared. Weight loss and physical activity lower them; ATP III notes that regular activity reduces VLDL.

Sources: [5] [1] [6]

How it travels in the blood

Labs measure triglycerides enzymatically in serum or plasma. The value also feeds the LDL calculation: the Friedewald formula is less accurate at triglycerides of 400 mg/dL or more, which the NIH equation was built to handle.

Sources: [7] [8] [9]

How long it lasts

Triglycerides are the lipid most affected by eating: the largest average rise 1 to 6 hours after normal meals is about 26 mg/dL (0.3 mmol/L). The European consensus suggests a fasting sample when non-fasting triglycerides are above 440 mg/dL.

Sources: [5]

What it does

In 7,587 women and 6,394 men from Copenhagen followed for a mean of 26 years, higher non-fasting triglycerides predicted heart attacks, ischemic heart disease and death. In 116,550 people, the risk of acute pancreatitis rose with triglycerides, to 8.7 times at 443 mg/dL or higher compared with below 89 mg/dL.

Sources: [3] [4]

Reference ranges

Triglycerides are read against risk categories. Labcorp prints 0-149 mg/dL; Quest prints below 150 for adults with lower limits for children; ATP III sets normal, borderline high, high and very high.

Labcorp (test 303756)

Method: Enzymatic (lipid panel; LDL calculated with the NIH equation). Labcorp test page (retrieved October 31, 2026).

GroupRange (mg/dL)
Adults (sample reports for women aged 31 and 64)0-149

Values above 149 are flagged high.

Quest Diagnostics (test 896)

Method: Spectrophotometry. Quest Diagnostics test page (retrieved October 31, 2026).

GroupRange (mg/dL)
20 years and older<150
Children and teens
GroupRange (mg/dL)
9 years and under<75
10-19 years<90

Read from Quest's test directory for the East service area.

NCEP Adult Treatment Panel III (NHLBI)

Clinical guideline thresholds (not a commercial lab's normal range). Method: Risk categories for adults, not a population reference interval. Guideline document (retrieved October 31, 2026).

GroupRange (mg/dL)
Normal<150
Borderline high150-199
High200-499
Very high500 or higher

ATP III triglyceride classification. The 2018 AHA/ACC guideline counted persistent triglycerides of 175 mg/dL or higher as a risk-enhancing factor.

Triglycerides vary more than the other lipids and rise after eating, so a single high non-fasting value is worth repeating.

Units: Labs outside the US report triglycerides in mmol/L. Divide mg/dL by 88 to convert, the factor used in the European lipid consensus: 150 mg/dL is about 1.7 mmol/L. [5]

Sources: [10] [11] [8] [1] [2] [5]

What raises it

FactorHowHow much
Recent mealPhysiologyTriglyceride-rich particles from the gut enter the blood after eating.Largest average rise about 26 mg/dL, 1-6 hours after normal meals [5]
Obesity, inactivity, smoking, excess alcohol, high-carbohydrate dietLifestyleATP III's list of common causes of high triglycerides.No published magnitude [1]
Type 2 diabetes, chronic kidney failure, nephrotic syndromeConditionDiseases ATP III lists as raising triglycerides.No published magnitude [1]
Corticosteroids, estrogens, retinoids, high-dose beta-blockersMedicationDrugs ATP III lists as raising triglycerides.No published magnitude [1]
GnRH drugs (Goserelin, Leuprolide)PeptideSex-hormone suppression raises triglycerides.+8.0 mg/dL over 6 months on goserelin in women with endometriosis [13] [14]

What lowers it

FactorHowHow much
GLP-1 and GIP/GLP-1 drugsPeptideTriglycerides fell more than any other lipid in the obesity trials of Tirzepatide and Semaglutide.-29.1% vs -5.6% on placebo (tirzepatide 15 mg) [6] [15]
TesamorelinPeptideTriglycerides fell with visceral fat in people with HIV.-50 mg/dL vs +9 mg/dL on placebo over 26 weeks [16]
Physical activityLifestyleATP III notes that regular activity lowers VLDL.No published magnitude [1]

Peptides that affect Triglycerides

How each peptide in our library changes triglycerides, from FDA label tables and trials. No study has measured triglycerides after dosing CJC-1295, Ipamorelin, HGH Fragment 176-191 or AOD-9604; a PubMed search for each peptide with cholesterol, triglycerides or lipids finds no human data (the only AOD-9604 lipid paper is a mouse study of fat loss, not blood lipids).

PeptideEffect on TriglyceridesSize of effectEvidence
MK-677 (Ibutamoren)RaisesNo figure in the abstract: in obese men, serum triglycerides rose at 2 weeks of MK-677; the authors describe the effect as transientA short-lived rise early in treatment. [17]Human trials
TesamorelinLowers26 weeks in people with HIV and abdominal fat: triglycerides -50 mg/dL vs +9 mg/dL on placebo (P < 0.001). A second trial: -37 mg/dL vs +6 mg/dLTriglycerides fell together with visceral fat in two randomized trials. [16] [18]Human trials
GoserelinRaisesWomen treated for endometriosis, 6 months: triglycerides +8.0 mg/dL on goserelin (danazol: a decrease)A small rise during estrogen suppression. [13]FDA label
LeuprolideRaisesNo size given: hyperlipidemia including triglycerides was recorded in 5% or more of men with prostate cancerThe label asks for lipid monitoring on GnRH agonists. [14]FDA label
LiraglutideLowersSaxenda 3 mg (Study 1, adults without diabetes): triglycerides -13% vs -4.1% on placebo; relative difference -7.1%A moderate fall in the weight-management trial. [19]FDA label
SemaglutideLowersWegovy 2.4 mg, 68 weeks (adults with obesity or overweight): triglycerides -21.9% vs -7.3% on placebo; relative difference -15.8%The largest lipid change semaglutide produces. [15]FDA label
TirzepatideLowersZepbound 15 mg, 72 weeks (Study 1): triglycerides -29.1% vs -5.6% on placebo; relative difference -24.9%A large, dose-related fall. [6]FDA label

What high or low results can mean

A high result

150-199 mg/dL is borderline high, 200-499 high and 500 or higher very high. High triglycerides track with heart attacks; very high levels also raise the risk of acute pancreatitis.

  • A recent meal (non-fasting sample)
  • Obesity, inactivity or excess alcohol
  • Type 2 diabetes or kidney disease
  • Drugs such as corticosteroids or estrogens

Next step: Repeat fasting if a non-fasting value is high, and discuss causes and overall risk with a clinician.

Sources: [1] [2] [3] [4] [5]

A low result

Below 150 mg/dL is normal. Low triglycerides are not usually a concern.

  • Fasting sample
  • Lean, active lifestyle

Next step: No action is usually needed.

Sources: [1] [10]

How the test works

SampleSerum (preferred) or plasma, 1 mL at Labcorp. Labcorp rejects samples in glycerinated tubes.
FastingIn a lipid panel fasting is not required. For a standalone triglyceride test, Labcorp asks for an overnight fast (12 hours preferred, 8 acceptable) and Quest for 9-12 hours. The European Atherosclerosis Society and EFLM recommend routine non-fasting lipid profiles: after normal meals, the largest average changes are +26 mg/dL for triglycerides and -8 mg/dL for total and LDL cholesterol, while HDL does not change. They suggest a fasting sample when non-fasting triglycerides are above 440 mg/dL.
TimingTriglycerides peak 1 to 6 hours after a meal, so the time since your last meal affects the result.
Lab differencesEnzymatic assay at Labcorp; spectrophotometry at Quest. Very high triglycerides make a calculated LDL less accurate.
RetestingA single high non-fasting value is worth repeating, ideally fasting, before drawing conclusions.
Labcorp order code001172: Triglycerides
Labcorp order code303756: Lipid Panel
Quest Diagnostics order code896: Triglycerides
Quest Diagnostics order code7600: Lipid Panel, Standard
LOINC codes
  • 2571-8: Triglyceride [Mass/volume] in Serum or Plasma
LOINC 2571-8 on loinc.org

Sources: [7] [20] [8] [5] [9]

History

Triglycerides moved from a fasting-only measurement to an accepted non-fasting marker of heart risk.

  1. 1977In older Framingham adults, triglycerides predict heart disease only in women, and only when other lipids are not taken into account. [21]
  2. 2001NCEP ATP III lowers the triglyceride cut-points and sets the normal, borderline, high and very high categories. [1] [2]
  3. 2007Copenhagen data show elevated non-fasting triglycerides predict heart attacks and death. [3]
  4. 2016European societies recommend routine non-fasting lipid profiles; mild-to-moderate high triglycerides are linked to acute pancreatitis. [5] [4]

FAQ

What is a normal triglyceride level?

Below 150 mg/dL for adults (ATP III, Labcorp 0-149, Quest below 150). Quest uses below 75 for children 9 and under and below 90 for ages 10-19.

Sources: [1] [10] [8]

Do I need to fast?

Not for a lipid panel. For a standalone triglyceride test Labcorp asks for an overnight fast and Quest 9-12 hours. A meal raises triglycerides by about 26 mg/dL at most.

Sources: [7] [8] [5]

When should I repeat a test fasting?

The European consensus suggests a fasting sample when non-fasting triglycerides are above 440 mg/dL.

Sources: [5]

What does 500 mg/dL or higher mean?

Very high in ATP III. Very high triglycerides raise the risk of acute pancreatitis: risk was 8.7 times higher at 443 mg/dL or more than below 89 mg/dL in a large Danish study.

Sources: [1] [4]

Are triglycerides linked to heart disease?

Yes. In Copenhagen adults followed for 26 years, higher non-fasting triglycerides predicted heart attacks, ischemic heart disease and death. The 2018 AHA/ACC guideline counted persistent triglycerides of 175 mg/dL or higher as a risk-enhancing factor.

Sources: [3] [12]

What raises triglycerides?

ATP III lists obesity, inactivity, smoking, excess alcohol, high-carbohydrate diets, type 2 diabetes, kidney disease and drugs such as corticosteroids, estrogens and retinoids.

Sources: [1]

Do GLP-1 drugs lower triglycerides?

Yes, more than any other lipid. In obesity trials triglycerides fell 29.1% on Tirzepatide 15 mg (vs 5.6% on placebo), 21.9% on Semaglutide 2.4 mg and 13% on Liraglutide 3 mg.

Sources: [6] [15] [19]

How does tesamorelin affect triglycerides?

In a 26-week trial in people with HIV and abdominal fat, triglycerides fell 50 mg/dL on Tesamorelin vs a 9 mg/dL rise on placebo; a second trial found -37 vs +6 mg/dL.

Sources: [16] [18]

Does MK-677 affect triglycerides?

In obese men, triglycerides rose in the first 2 weeks of MK-677 (Ibutamoren); the authors describe the effect as transient.

Sources: [17]

Why do high triglycerides affect my LDL result?

Most labs calculate LDL using triglycerides. The Friedewald formula is less accurate at 400 mg/dL or more; the NIH equation and direct LDL tests help.

Sources: [9] [22]

References

  1. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive Summary. NIH Publication No. 01-3670. National Heart, Lung, and Blood Institute; 2001. Table 2 (LDL, total and HDL cholesterol classification), triglyceride classification and Table 8 (metabolic syndrome). nhlbi.nih.gov/files/docs/guidelines/atp3xsum.pdf
  2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97. PMID 11368702
  3. Nordestgaard BG, Benn M, Schnohr P, et al. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298(3):299-308. PMID 17635890
  4. Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute Pancreatitis. JAMA Intern Med. 2016;176(12):1834-1842. PMID 27820614
  5. Nordestgaard BG, Langsted A, Mora S, et al. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J. 2016;37(25):1944-58. PMID 27122601
  6. Zepbound (tirzepatide) injection. FDA prescribing information, Table 3 (cardiometabolic parameters, Studies 1 and 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
  7. Labcorp. Test 001172: Triglycerides. Methodology, specimen, patient preparation and LOINC map. labcorp.com/tests/001172/triglycerides
  8. Quest Diagnostics. Test 896: Triglycerides. Test directory: methodology, patient preparation, age-banded reference range and clinical significance. testdirectory.questdiagnostics.com/test/test-detail/896/triglycerides?cc=PHP
  9. Sampson M, Ling C, Sun Q, et al. A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and/or Hypertriglyceridemia. JAMA Cardiol. 2020;5(5):540-548. PMID 32101259
  10. Labcorp. Sample report, test 303756 (Lipid Panel): reference intervals as printed for a 31-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/303756.pdf
  11. Labcorp. Sample report, test 235010 (Lipid Panel With LDL/HDL Ratio): reference intervals as printed for a 64-year-old woman (reported 06/10/2024). files.labcorp.com/testmenu-d8/sample_reports/235010.pdf
  12. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1082-e1143. PMID 30586774
  13. Zoladex (goserelin implant) 3.6 mg. FDA prescribing information: lipid changes in women treated for endometriosis. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=294b168b-6e5f-4db9-bf70-d599271458b3
  14. Lupron Depot (leuprolide acetate) 7.5 mg, 22.5 mg, 30 mg, 45 mg. FDA prescribing information: Warnings (metabolic syndrome) and laboratory abnormalities. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbc8f94e-7330-4465-05ad-16d64493a5dd
  15. Wegovy (semaglutide) injection 2.4 mg. FDA prescribing information, Table 10 (cardiometabolic parameters, Study 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  16. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-70. PMID 18057338
  17. Svensson J, Jansson JO, Ottosson M, et al. Treatment of obese subjects with the oral growth hormone secretagogue MK-677 affects serum concentrations of several lipoproteins, but not lipoprotein(a). J Clin Endocrinol Metab. 1999;84(6):2028-33. PMID 10372705
  18. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010;95(9):4291-304. PMID 20554713
  19. Saxenda (liraglutide) injection 3 mg. FDA prescribing information, Table 6 (cardiometabolic parameters, Study 1). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143
  20. Labcorp. Test 303756: Lipid Panel. Components, specimen, patient preparation and LOINC map. labcorp.com/tests/303756/lipid-panel
  21. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med. 1977;62(5):707-14. PMID 193398
  22. Labcorp. Test 120295: Low-density Lipoprotein Cholesterol (Direct). Methodology, patient preparation and LOINC map. labcorp.com/tests/120295/low-density-lipoprotein-cholesterol-direct

Educational information, not medical advice. Lab ranges and test codes were checked on October 31, 2026. Always use the range printed on your own report, and talk to a clinician about your results.